Story · Medicine & Biotech · Mind & Brain

Marco Donia: TIL Therapy Without Systemic IL-2 in Melanoma

1 outlet · first reported by OncoDaily on

Marco Donia, Professor of Clinical Oncology at University of Copenhagen, shared on LinkedIn: “TIL therapy without systematic IL-2: a step toward more accessible cell therapy” High-dose IL-2 made TIL therapy (OncoDaily)

Coverage, in order

  1. OncoDaily obscure study
    Marco Donia: TIL Therapy Without Systemic IL-2 in Melanoma

    Marco Donia, Professor of Clinical Oncology at University of Copenhagen, shared on LinkedIn: “TIL therapy without systematic IL-2: a step toward more accessible cell therapy” High-dose IL-2 made TIL therapy

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.